Search Results
Found 9 results
510(k) Data Aggregation
K Number
K141816Device Name
HEMOPORE
Manufacturer
Polyganics BV
Date Cleared
2014-10-23
(108 days)
Product Code
LYA
Regulation Number
874.4780Why did this record match?
Applicant Name (Manufacturer) :
Polyganics BV
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
HEMOPORE® is intended for use in patients undergoing nasal/simus surgery as a temporary wound dressing.
HEMOPORE® functions as a topical hemostatic aid to control mild bleeding by tamponade effect, blood absorption, platelet activation and aggregation.
It acts as an adjunct to aid in the natural healing process as a space occupying stent to separate and support tissues. It prevents adhesions and minimizes edema.
Device Description
HEMOPORE® is a sterile fragmentable nasal dressing of 8 cm composed of poly(DL-lactide-cos-caprolactone) urethane and blended with a chitosan derivate and a violet color additive.
After insertion of HEMOPORE®in the nasal cavity, fluids will be absorbed by the dressing, which helps to control bleeding after surgery.
The dressing fragments within several days by hydrolyzing ester bonds, whereafter it is drained from the nasal cavity via the natural mucus flow.
The HEMOPORE® is sterilized in a blister package. The device is single-use, cannot be resterilized, and is a prescription product.
Ask a Question
K Number
K141423Device Name
NASOPORE-FD
Manufacturer
Polyganics BV
Date Cleared
2014-08-07
(69 days)
Product Code
LYA
Regulation Number
874.4780Why did this record match?
Applicant Name (Manufacturer) :
Polyganics BV
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
NASOPORE ® FD is a fragmentable nasal dressing and is indicated for use in patients undergoing nasal/sinus surgery as a space occupying stent to separate and prevent adhesions between mucosal surfaces; to help control minimal bleeding following surgery or nasal trauma by tamponade effect and blood absorption.
Device Description
NASOPORE "FD is composed of a bioresorbable poly(DL-lactide-co-s-caprolactone) urethane that fragments within several days after insertion in the nasal cavity, whereafter it is drained from the nasal cavity via the natural mucus flow.
The NASOPORE® FD size and type are indicated on the label and are packed in a blister. NASOPORE "FD is indicated for single-use.
The modification in this submission concerns a line extension to the predicate device NASOPORE "with a NASOPORE" FD that fragments faster than the cleared predicate device.
Ask a Question
K Number
K112267Device Name
NEUROLAC(R) NERVE GUIDE
Manufacturer
Polyganics BV
Date Cleared
2011-10-20
(73 days)
Product Code
JXI
Regulation Number
882.5275Why did this record match?
Applicant Name (Manufacturer) :
Polyganics BV
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Neurolac® nerve guide is indicated for the reconstruction of a peripheral nerve discontinuity up to 20 mm in patients who have sustained a complete division of a nerve.
Device Description
Neurolac® is designed to be a flexible and transparent resorbable poly(DL-lactide- co-e-caprolactone) tube to provide a protective environment for peripheral nerve reqeneration after injury and to create a conduit to quide axonal growth across a nerve gap. Neurolac® nerve guides are provided sterile in Tyvek pouch packages and retainer in a variety of sizes. The modification in this submission concerns a line extension to the predicate devices with a thinner wall thickness.
Ask a Question
K Number
K070715Device Name
NASOPORE EAR
Manufacturer
Polyganics BV
Date Cleared
2007-05-07
(54 days)
Product Code
NHB
Regulation Number
874.3620Why did this record match?
Applicant Name (Manufacturer) :
Polyganics BV
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Nasopore® Ear is a fragmentable ear packing and is indicated for use in patients, undergoing ear surgery, as a space occupying stent to separate and prevent adhesions between mucosal surfaces; to help control minimal bleeding, following ear surgery, by tamponade effect and blood absorption.
Device Description
Nasopore® Ear is composed of a bioresorbable poly(DL-lactide-co-s-caprolactone) urethane that fragments within several days after insertion in the outer and / or middle ear, whereafter it will fall out of the ear or leaves the body by the natural mucus flow. The type of Nasopore® Ear is indicated on the label. Nasopore® Ear is packed in a blister closed by a medical paper lid. Nasopore® Ear is indicated for single-use.
Ask a Question
K Number
K062540Device Name
NASOPORE EAR, MODELS ND04, ND05
Manufacturer
Polyganics BV
Date Cleared
2006-10-18
(49 days)
Product Code
KCN
Regulation Number
874.5220Why did this record match?
Applicant Name (Manufacturer) :
Polyganics BV
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Nasopore® Ear is a fragmentable ear packing and is indicated for use in patients, undergoing outer ear surgery, as a space occupying stent to separate and prevent adhesions between mucosal surfaces; to help control minimal bleeding, following ear surgery, by tamponade effect and blood absorption.
Device Description
Nasopore® Ear is composed of a bioresorbable poly(DL-lactide-co-sscription caprolactone) urethane that fragments within several days after insertion in the outer ear, whereafter it is drained from the cavity. The type of Nasopore® Ear is indicated on the label. Nasopore® Ear is packed in a blister closed by a medical paper lid. Nasopore® Ear is indicated for single-use.
Ask a Question
K Number
K052099Device Name
NASOPORE NASAL DRESSING, MODEL NDOX-YYY/ZZ
Manufacturer
Polyganics BV
Date Cleared
2005-11-21
(110 days)
Product Code
LYA
Regulation Number
874.4780Why did this record match?
Applicant Name (Manufacturer) :
Polyganics BV
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Nasopore is a fragmentable nasal dressing and is indicated for use in patients undergoing nasal/sinus surgery as a space occupying stent to separate and prevent adhesions between mucosal surfaces; to help control minimal bleeding following surgery or nasal trauma by tamponade effect and blood absorption.
Device Description
Nasopore is composed of a fragmentable poly(DL-lactide-co-e-caprolactone) urethane that fragments within several days after insertion in the nasal cavity, whereafter it is drained from the nasal cavity via the natural mucus flow. The Nasopore size and type are indicated on the label and are packed in a Tyvek pouch. Nasopore is indicated for single-use.
Ask a Question
K Number
K050573Device Name
NEUROLAC NERVE GUIDE
Manufacturer
Polyganics BV
Date Cleared
2005-05-04
(58 days)
Product Code
JXI
Regulation Number
882.5275Why did this record match?
Applicant Name (Manufacturer) :
Polyganics BV
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Neurolac nerve guide is indicated for the reconstruction of a peripheral nerve discontinuity up to 20 mm in patients who have sustained a complete division of a nerve.
Device Description
Neurolac® (4-10 mm) is designed to be a flexible and transparent resorbable poly(DL-lactide-co-s-caprolactone) tube to provide a protective environment for peripheral nerve regeneration, for nerves with an internal diameter ≤ 9.5 mm, after injury and to create a conduit to guide axonal growth across a nerve gap. Neurolac® (4-10mm) nerve guides are provided sterile in Tyvek pouch packages and retainer in a variety of sizes (4, 5, 6, 7, 8, 10 mm).
Ask a Question
K Number
K042811Device Name
VIVOSORB SHEET, MODEL FS01
Manufacturer
Polyganics BV
Date Cleared
2004-11-08
(27 days)
Product Code
FTL
Regulation Number
878.3300Why did this record match?
Applicant Name (Manufacturer) :
Polyganics BV
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The VivoSorb Sheet is indicated for the use as a temporary wound support, to reinforce soft tissues where weakness exists, or for the repair of hernia or other fascial defects that require the addition of a reinforcing material to obtain the desired surgical result. The resorbable protective film minimizes tissue attachment to the device in case of direct contact with the viscera.
Device Description
The VivoSorb Sheet is designed to be a flexible and transparent resorbable Device poly (DL-lactide-co-s-caprolactone) sheet to provide support to soft tissue Description where weakness exists. The VivoSorb Sheet is provided sterile in Tyvek pouch packages in a variety of sizes.
Ask a Question
K Number
K032115Device Name
NEUROLAC NERVE GUIDE MODELS NG01-15/03, NG01-020/03, NG01 025/03, NG01-030/03
Manufacturer
Polyganics BV
Date Cleared
2003-10-10
(93 days)
Product Code
JXI
Regulation Number
882.5275Why did this record match?
Applicant Name (Manufacturer) :
Polyganics BV
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Neurolac® nerve guide is indicated for the reconstruction of a peripheral nerve discontinuity up to 20 mm in patients who have sustained a complete division of a nerve.
Device Description
Neurolac® is designed to be a flexible and transparent resorbable poly(DL-lactide-co-ε-caprolactone) tube to provide a protective environment for peripheral nerve regeneration after injury and to create a conduit to guide axonal growth across a nerve gap.
Neurolac® nerve guides are provided sterile in Tyvek pouch packages and retainer in a variety of sizes.
Ask a Question
Page 1 of 1